Abraham Avigdor

Specialization: Hematologist
35 years of experience
Speaks:
English, Hebrew
Online consultations: available
Workplace: Israel, Ramat Gan, Sheba Medical Center
Director of the Institute of Hematology; founder and president of the Israeli Lymphoma Working Group; author of 130+ scientific publications.
Dr. Abraham Avigdor is the Director of the Institute of Hematology at Sheba Medical Center. He is a global authority on lymphoma, CAR-T therapy, and complex blood cancers. Dr. Avigdor founded the Israeli Lymphoma Working Group. He helps lead a clinic ranked 7th worldwide by Newsweek in 2026.
- Authored over 130 scientific publications on hemato-oncology and cellular therapy.
- Pioneered the integration of CAR-T cell therapy for lymphoma and myeloma.
- Leads allogeneic and autologous bone marrow transplantation programs.
- Served as the Chairman of the Israeli Lymphoma Study Group.

Online consultation with Abraham Avigdor

Convenient and easy

100% secure and confidential

$650

How are we doing?

1 of 3

Information about this doctor is full and clear

Strongly disagree

Strongly agree

Qualifications

Prof. Abraham Avigdor directs the Institute of Hematology at Sheba Medical Center. He specializes in CAR–T therapy, lymphoma, and hemato-oncology. The specialist founded the Israeli Lymphoma Working Group and serves as its President. He uses his experience to lead programs in bone marrow transplantation and cellular therapies.

Specialization and Hematologic Focus

Dr. Avigdor treats blood cancers and immune system disorders. He specializes in lymphomas, including Hodgkin, Non-Hodgkin, and Burkitt’s lymphoma. The specialist also treats multiple myeloma, acute lymphoblastic leukemia, and various types of anemia. He integrates immunotherapy and targeted biological treatments into his practice.

His therapeutic approach integrates several techniques:

CAR–T Cell Therapy for lymphoma and myeloma
Bone Marrow Transplantation including autologous and allogeneic procedures
Haploidentical Stem Cell Transplantation — a procedure using healthy blood-forming cells from a half-matched donor to replace diseased bone marrow
Precision Diagnostics using PET/CT imaging as a prognostic tool
Immunotherapy and biological targeted regimens
Therapeutic Apheresis and plasma exchange protocols — methods that filter blood to remove harmful substances or abnormal cells

Academic and Clinical Leadership

Dr. Avigdor holds leadership positions at Sheba Medical Center and national bodies. He co-directs the Hematology and Bone Marrow Transplantation Division. Between 2011 and 2018, he served as Chairman of the Israeli Lymphoma Study Group. The specialist currently sits on the National Hematology Consultation Committee for the Health Basket.

Research and Professional Societies

The doctor contributes to medical science through clinical trials and partnerships. He has authored over 130 scientific publications. Dr. Avigdor collaborates with international organizations including:

Lymphoma Study Association (LYSA), France
European Mantle Cell Lymphoma Network (EMCL)
International PET Study Groups in Lymphoma and Myeloma

Work Experience

Director – Institute of Hematology, Sheba Medical Center
Co-Director – Hematology and Bone Marrow Transplant Division, Sheba Medical Center
Senior Lecturer – Tel Aviv University
Former Chairman – Israeli Lymphoma Study Group (2011–2018)
Founder and President – Israeli Lymphoma Working Group

Education and Training

Medical Degree – Ben-Gurion University of the Negev
Residency – Internal Medicine and Hematology, Sheba Medical Center
Postdoctoral Fellowship – Stem Cell Biology, Weizmann Institute of Science

Awards and Recognition

Knesset Prize – for excellence in medical studies
Ministry of Health Award – for outstanding physician performance
Sackler Prize – for research excellence at Tel Aviv University